Jiangxi Provincial People's Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02728180
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

12.Jiangxi Provincial People's Hospital | JIANGXI Provincal People's Hospital | Jiangxi Provincial People's Hopital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Aplastic (Phase 4)

Cerebral Infarction (Phase 4)

Hyperphosphatemia (Phase 3)

Ischemia (Phase 4)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 13